1. The Field of the Invention
The present invention relates to a femoral hip prosthesis for replacing a portion of proximal femoral bone during hip replacement and the methods of assembly and use thereof.
2. The Relevant Technology
Total hip arthroplasty using a metallic hip prosthesis has been successfully performed since the early 1960's and is now a routine procedure to address orthopedic diseases such as osteoarthritis, fracture, dislocations, rheumatic arthritis, and aseptic or avascular bone necrosis. During this procedure, the bone is prepared for the prosthesis by removing the damaged articulating end of the bone by resecting a portion of the bone including the femoral head. This exposes the inside, of the metaphaseal region of the intramedullary canal in the proximal femur. The surgeon then drills or reams a cavity in the femur approximately in line with the intramedullary canal. This cavity is used to align other tools such as reamers, broaches and other bone tissue removal instruments to create a roughly funnel shaped bone cavity that is smaller in cross-section as it extends down from the bone resection at the proximal end of the femur into the distal intramedullary canal. This funnel shaped cavity is typically also eccentric with more bone material removed from the medial calcar region of the proximal femur than the region on the lateral side of the canal.
Oftentimes a grouting agent commonly referred to as bone cement is then added to the funnel shaped cavity. Once the prosthesis is inserted into the cavity, this creates a bone cement mantle between the prosthesis and the bone. Sometimes the shape of the cavity is prepared to closely match the shape of the external surface of the prosthesis, and the prosthesis is press fit into the cavity without the use of bone cement. These press-fit prostheses typically have a textured bone-ingrowth surfaces place strategically at specific locations on their surface to help facilitate lone-term bone tissue growth into the prosthesis. This bone ingrowth into the porous structure on the implant creates a long lasting secure bond between the prosthesis and the proximal femur.
Once the bone cavity is prepared, the prosthesis is placed into the bone cavity and is supported directly by internal bone tissue in the case of a press fit implant or indirectly by the bone cement mantle in the case of the cemented implant. Then, the prosthesis is aligned such that the articulating end of the implant articulates with the opposite side of the natural joint in the case of a hemiarthoplasty, or articulates with a corresponding implant replacing the opposite side of the joint in the case of a total joint arthroplasty.
Current designs of proximal femur hip prosthesis have eccentric, non-symmetric cone shaped central body portions. The current methods of implant fixation allow for transfer of axial loads to the proximal femur mainly through shear stresses at the eccentric funnel shaped bone-prosthesis interface. The effective transfer of load is significantly dependent on the three-dimensional shape of funnel shaped cavity, the bone-prosthesis or bone-cement-prosthesis interface as well as physiological loading of the proximal end. Partly because of the eccentrically shaped cross-section of the central body portion, these currently available prostheses transmit radial expansion forces on the proximal femoral cavity as the implant is loaded in compression. The funnel shape of the cavity and the matching shape of the implant or bone cement result in circumferential hoop stresses and radial expansion stresses are distributed to the bone as the femoral component is axially loaded. This results in complex axial and shear stresses at the bone-implant interface. Consequently, the distribution of the loads that transmit from the femoral head axially through the proximal femur is altered after THA.
A potential cause of failure of currently used prosthesis is associated with the possible resorption of the bone surrounding the implant. The bone resorption can be the result of an altered distribution of shear stresses on the remaining proximal femoral tissue. In time, the lack of adequate stress transfer from the metal stem to the surrounding bone may cause a loss of bone density, resulting in the increased possibility of bone failure or loosening of the bone-prosthesis interface. The gradual loss of bone support in the calcar region of the eccentric cavity increases the bending load that must be borne by the prosthesis. This increase in bending load on the prosthesis can lead to stress shielding by the prosthesis resulting in prosthesis fatigue and potentially to eventual clinical failure.
The present invention is directed to a femoral hip prosthesis that satisfies the need for anatomically distributing the dynamic compressive loads on the hip joint to the proximal femoral bone. The femoral hip prosthesis is adapted for implantation against a resected surface on a proximal end of a femur, and also in an intramedullary cavity of the femur. The femoral hip prosthesis comprises femoral head component and a femoral stem component. The femoral stem component comprises a neck portion, a flange portion, a transitional body portion, and an elongated stem portion. The neck portion comprises a proximal male friction fit portion and a distal neck body. The flange portion is distal and adjacent to the neck portion and is attached to the distal neck body. The flange portion comprises an upper portion and a bottom surface. The transitional body region is adjacent to the bottom surface of the flange portion and also extends from the distal neck body. The elongated stem portion extends distally from the transitional body region and is aligned with a longitudinal axis. The longitudinal axis is oriented at an acute angle relative to the bottom surface of the flange portion. The elongated stem portion comprises a uniform envelope that may contain rotation-restricting splines, a tapered portion or a transverse slot. The femoral hip prosthesis may also alternatively contain a rotation-restricting boss that is attached to the bottom of the flange portion. The femoral hip prosthesis also comprises a distal end tip portion on the distal end of the elongated stem portion.
Various embodiments of the present invention will now be discussed with reference to the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope.
a is an embodiment of a substantially circular cross-section of the elongated stem portion;
b is an embodiment of a substantially square cross-section of the elongated stem portion;
c is an embodiment of a substantially triangular cross-section of the elongated stem portion;
d is an embodiment of a substantially hexagonal cross-section of the elongated stem portion;
e is an embodiment of a substantially star shaped cross-section of the elongated stem portion;
Depicted in
The femoral hip prosthesis 50 comprises a femoral head component 700 and a femoral stem component 100. The femoral stem component 100 comprises a neck portion 150, a flange portion 200, a transitional body portion 300, an elongated stem portion 400, and a distal tip end 500. The non-eccentric symmetrical shape of the interface between the elongated stem portion 400 of the femoral stem component 100 and a cavity 25 along with the contact at the interface between a proximal resection 20 and the femoral stem component 100 helps to stabilize the femoral hip prosthesis 50 and transfer more anatomic loads from the prosthesis 50 to the bone efficiently.
To prepare the patient for a proximal femoral hip prosthesis 50, the surgeon first makes an incision or incisions near the hip joint, then the surgeon cuts though some of the tissue near the articulating joint, and retracts these tissues apart to visualize and access the diseased bone structures that are to be replaced by the hip joint replacement prostheses.
The intramedullary cavity 25 may have a multiple diameters, or in the case of non-circular cross-sectionally shaped cavities multiple sizes, to approximately match the shape of the femoral stem component 100.
After the basic intramedullary cavity 25 is formed, instrumentation (not shown) is used to align cutting guides for bone cutting instruments (not shown) to form a proximal resection 20 on the proximal femur 10. The proximal resection 20 may have different surfaces such as a calcar resection surface 12 that is formed when the femoral calcar 11 is transverely cut through the proximal femur 10. The calcar resection surface 12 is cut at an acute angle 22 with respect to the longitudinal axis 21 of the proximal femur 10. This acute angle is typically between 10° and 80°. Although the proximal resection 20 may be simply one continuous transverse cut that passes from the medial to the lateral side of the proximal femur in the direction and plane defined by a the plane outlined by the dashed line 16 shown in
More bone conserving cuts may also be formed in to the proximal femur 10 as shown in
After the intramedullary cavity 25 and the proximal resection 20, including the calcar resection 12 and when applicable other bone tissue removal cuts are formed, the femoral stem component 100 can be inserted to mate with the exposed bone surfaces. The femoral stem component 100 comprises a proximal male friction fit portion 150, a distal neck body 160, a flange portion 200, a transitional body portion 300, an elongated stem portion 400, and a distal end tip portion 500. These portions will be discussed in detail below.
The femoral stem component 100 has a proximal male friction fit portion 150 on its most proximal end that is shaped to accept partially hemispherical femoral head component 700. One shape of the proximal male friction fit portion 150 is a cylindrical taper shape with the smaller diameter on the male friction fit portion proximal section 151, a tapered male friction fit portion 152 distal to the male friction fit portion proximal section 151, and a larger diameter male friction fit portion taper maximum cross-section bottom end 153 on the distal end of the male friction fit portion 152. The proximal male friction fit portion 150 could also be a straight cylindrical shape without a taper, or a series of successively larger diameter cylindrical shapes.
A femoral head component 700 has a male cavity 720 that is dimensioned to fit over and mate with the friction fit portion 152 of the proximal male friction fit portion 150 when the femoral head component 700 is assembled on the proximal male friction fit portion 150. The femoral head prosthesis 700 has an external bearing surface portion 710 on its external surface that is substantially on its proximal side when implanted. The external bearing surface portion 710 of the femoral head prosthesis 700 is substantially hemispherical shaped on a portion of its load bearing external bearing surface. This hemispherical shape is designed to mate with either an artificial prosthetic acetabular cup surface (not shown) as is the case for a total hip arthroplasty or a natural acetabular surface as is the case for a hip femoral hemiplasty.
The proximal male friction fit portion 150 has a male friction fit portion neck 154 that is distal to the male friction fit portion portion 152 and adjacent to the male friction fit portion taper bottom end 153. This male friction fit portion neck 154 functions as an undercut relief for the femoral head component 700 when assembled. Because the male friction fit portion neck 154 is smaller in diameter than the male friction fit portion portion 152, the femoral head component 700 can be pressed onto the proximal male friction fit portion 150 with the only direct contact between the two on the friction fit portion 152 of the femoral stem component 100 and the male friction fit portion 720 of the femoral head component 700.
The male friction fit portion neck 154 is proximal to and attached directly to a more bulky distal neck body 160. The distal neck body 160 is shaped to distribute the loads transmitted through the proximal male friction fit portion 150 from the femoral head component 700 through a flange portion 200 and a transitional body portion 300. The shape of the distal neck body 160 transitions from a simple symmetric shape similar to the cross-section of the male friction fit portion neck 154 to a more complex asymmetric shape that is similar to the combined shape of the flange portion 200 and the transitional body portion 300. In the embodiment shown in
The flange portion 200 has an upper portion 210 on its proximal side that contacts at least a part of the distal neck body 160. In the embodiments shown in
The flanged portion 200 is less thick than it is wide. As shown in the embodiment of
The transitional body region 300 is the portion of the femoral stem component 100 that transitions from the distal neck body 160 and the flange portion 200 to the distal elongated stem portion 400. The transitional body region 300 is adjacent to both the distal neck body 160 and the flange portion 200 on its proximal side and adjacent to the elongated stem portion 400 on its distal side. The transitional body portion 300 has a maximum height 310 that is the linear distance measured between a plane tangent to the bottom surface 220 of the flange portion 200 and a plane through the most distal part of the transitional body portion 300. In
Conventional orthopedic alloys such as cobalt chrome, titanium and stainless steel alloys and orthopedic composite materials have proven to provide reasonable strength and rigidity to orthopedic implants and may also be used to fabricate the femoral stem component 100. However, when conventional orthopedic alloys or composites are fabricated into the eccentric conical shape of a typical femoral stem component 100, the resulting implant is more rigid than the proximal femoral 10 that the femoral stem component 100 is replacing. Flexibility of the stem component 100 is necessary to allow the flex and compliance desired to dynamically anatomically load the proximal femur 10 bone during biomechanical loading. The relatively small shape of the transitional body portion 300 allows for more flexion of the flange portion 200 when the proximal male friction fit portion 150 is loaded than is seen with the bulkier conventional eccentric cone shaped femoral prosthesis. The unique shape of the femoral stem component 100 allows for flexibility of the prosthesis even when fabricated from rigid orthopedic alloys such as such as cobalt chrome, titanium and stainless steel alloys.
This dynamic flexibility within the transitional portion 300 is desired since it allows the flange portion 200 of the femoral stem component 100 to transmit loads and displacements to the femoral calcar region 11 of the proximal femur 10. When bone is loaded and allowed to deform, a piezoelectric effect within the tissue simulate the bone cells into further production. This phenomenon, sometimes called Wolfs Law, coupled with other physiologic and biochemical principles, helps to keep the bone surrounding the femoral hip prosthesis 50 healthy and vibrant. The femoral stem component 100 is designed to optimize the effects that a flexible, yet strong femoral hip prosthesis 50 will have on the surrounding loaded bone tissue. As the hip joint is loaded during clinical use, loads are transmitted through the male friction fit portion 154 and distal neck body 160 to the flange portion 200 and the transitional body portion 300 to the stem. Since the transitional body portion 300 is relatively flexible and not as bulky and rigid as a conventional femoral hip prosthesis, the transitional body portion 300 allows the femoral stem component 100 to flex and transmit the compressive load to the bone in the calcar region 11 of the proximal femur 10. These loads on the bone may allow the dynamization necessary to keep the tissue surrounding the femoral stem component 100 healthy and help prevent bone resorption in the calcar region 11 of the proximal femur 10.
Distal and adjacent to the transitional body portion 300 is the elongated stem portion 400. The elongated stem portion 400 comprises some or all of the following portions and features; a tapered portion 450, a splined section 420, and transverse slot 480. The elongated stem portion is encompassed within a cylindrically shaped envelope referred to as uniform envelope 410. The cross-sectional shape and the area of the uniform envelope 410 remains substantially uniform throughout the longitudinal length of the elongated body. The uniform envelope 410 has a circular uniform cross-sectional periphery 902 that is defined by the maximum cross-sectional peripheral diameter 905 of the elongated stem portion 400. The uniform envelope 410 is the same length as the elongated stem portion. The elongated stem portion is adjacent to the transitional body portion 300 on its proximal end and adjacent to a distal tip portion 500 on its distal end.
As shown in
Material may be removed from the elongated stem portion 400 to created features such as taper portions 450, splines 460 or the transverse slots 480. However, the basic substantial shape of the external periphery of the cross-section of the elongated stem portion 400 remains uniform and circular. Thus, the elongated stem portion and the uniform envelope 410 are both substantially symmetric and non-eccentric. The embodiment of the elongated stem portion 400 shown in
In the embodiments shown, the longitudinal axis 425 of the elongated stem portion 400 is a substantially straight axis throughout the length of the elongated stem portion 400. However, to better match the anatomy of the proximal femur 10, the longitudinal axis 425 can also be curved. The curve may be in the anterior-posterior plane, the medial-lateral plane or a compound curve that is seen in both the anterior-posterior plane and the medial-lateral plane. A flexible reamer (not shown) could be used to form the curved intramedullary cavity before the prosthesis 10 with a curved longitudinal axis 425 is implanted.
The elongated stem portion 400 may include a tapered portion 450 along its length. This is shown in
Features such the splines 460 are cut into the elongated stem portion 400 for various structural and functional reasons such as to provide additional torsional resistance to the femoral stem component 100. In the embodiments shown, the splines 460 are evenly spaced around the periphery 902 of the distal elongated stem portion 400. The splines 460 are cut longitudinal around the periphery 902 of the elongated stem portion 400. This allows the splines 460 to resist axial rotation between the femoral stem component 100 and the intramedullary cavity 25. The splines 460 may also provide additional structural flexibility to the distal end of the femoral stem component 100.
At the distal end of the femoral stem component 100, an optional longitudinal transverse slot 480 may be cut transversely into the elongated stem portion 400 to provide additional flexibility and potentially additional torsional resistance to the femoral stem component 100. The embodiment of the slot 480 that is shown is substantially uniform in cross-sectional and in shape though its length. The cross-sectional shape of the slot 480 may also be non-uniform. The cross-sections shape of the slot 480 may also change. For example the sides of the slot 481 may change from parallel planar surfaces to non-parallel or non-planar surfaces as the slot transitions from distal to proximal. The slot 480 also has a fillet 485 that takes the form of a rounded radius shape at its most proximal end. The shape of this fillet 485 may be other shapes that allow a relatively smooth transition from the slot 480 to the non-slotted cross-section. For example the slot 480 may be keyhole shaped.
Adjacent and distal to the elongated stem portion is the distal end tip portion 500. The distal end tip portion 500 has a lead-in section 510 that reduces in cross-sectional area from proximal to distal. The lead-in section may be tapered as in the embodiment of
The load distribution on the proximal femur 10 of an intact hip joint can be essentially resolved into an axial component, a bending moment in the medial and lateral direction, a bending moment in the anterior posterior direction, and a torsional moment with a rotational axis approximately in line with the longitudinal axis 21 of the proximal femur. The distribution of the magnitude and direction of these force components depend upon complex combinations of biomechanical factors such as leg stance, patient weight distribution, and patient gait. The femoral stem component 100 is designed to translate these forces to anatomic loads on the proximal femur 10. As described above, the flange portion 200 helps to translate the compressive loads to the cancellous bone 3 and cortical bone 4 in the calcar region 11. The elongated stem portion 400 helps to transmit the bending and torsional moments to the intramedullary canal 25. In addition, a rotation-restricting boss 600 helps to transmit some of the torsional moments to the bone in the calcar region 11 of the proximal femur 10. As shown in
The size and location of the rotation-restricting boss 600 are factors that affect the amount that the rotation-restricting boss 600 restricts rotational movement of the femoral stem component 100. Due to greater resistance from a rotation-restricting boss with a larger resultant moment arm, the further that the rotation-restricting boss 600 is located from the longitudinal axis 425 of the elongated stem portion 400, the more effective it is in transmitting rotational loads and restricting rotational movement of the femoral stem component 100 to the proximal femur 10. Also, the larger the cross-sectional area of the rotation-restricting boss 600, the more effective it is in distributing torsion and restricting rotational movement of the femoral stem component 100.
The embodiments of the rotation-restricting boss 600 that are shown by example are circular in cross-section resulting in a cylindrical shaped boss. However, other cross-sectional shapes such as square, rectangular, triangular or diamond shapes may be more practical to machine or may be better at distributing torsional loads from the femoral hip prosthesis 50 to the proximal femur 10 than the shown cylindrically shaped rotation-restricting boss 600. The optimized shape of the rotation-restricting boss 600 may be more fin shaped than cylindrical shaped or longer than it is wide. This shape is partially dependent on the mechanical characteristics of the bone tissue where the rotation-restricting boss 600 is inserted.
The rotation restricting boss 600 has an axis of protrusion 620 with origin 621 substantially on a plane tangent or coincident with the bottom surface 220 of the flange portion 200. The boss axis of protrusion origin 621 and the stem portion longitudinal axis 425 are spaced apart by a length this is more than the maximum length 905 of the cross-section of the periphery 902 of the uniform envelope 410 of the elongated stem portion 400.
The rotation-restricting boss 600 in the embodiment of the prosthesis 10 shown in
As shown in
While the present invention has been disclosed in its preferred form, the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense, as numerous variations are possible. The invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. No single feature, function, element or property of the disclosed embodiments is essential. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. The following claims define certain combinations and subcombinations that are regarded as novel and non-obvious. Other combinations and subcombinations of features, functions, elements and/or properties may be claimed through amendment of the present claims or presentation of new claims in this or related applications. Such claims, whether they are broader, narrower or equal in scope to the original claims, are also regarded as included within the subject matter of applicant's invention. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a Continuation of the following, which is herein incorporated by reference: U.S. patent application Ser. No. 12/429,882 filed Apr. 29, 2009, and is entitled FEMORAL HIP PROSTHESIS AND METHOD OF IMPLANTATION, which is a continuation of the following: U.S. patent application Ser. No. 10/763,314 filed Jan. 22, 2004, now U.S. Pat. No. 7,534,271, and is entitled FEMORAL HIP PROSTHESIS AND METHOD OF IMPLANTATION.
Number | Name | Date | Kind |
---|---|---|---|
3512184 | Grover | May 1970 | A |
3658056 | Huggler et al. | Apr 1972 | A |
3683421 | Martinie | Aug 1972 | A |
3782373 | Smythe | Jan 1974 | A |
3848272 | Noiles | Nov 1974 | A |
3864758 | Yakich | Feb 1975 | A |
3871031 | Boutin | Mar 1975 | A |
3894297 | Mitttelmeier et al. | Jul 1975 | A |
3916451 | Buechel et al. | Nov 1975 | A |
4001897 | Rambert et al. | Jan 1977 | A |
4005495 | Locke et al. | Feb 1977 | A |
4012795 | Dorre et al. | Mar 1977 | A |
4012796 | Weisman et al. | Mar 1977 | A |
4021865 | Charnley | May 1977 | A |
4080666 | Fixel | Mar 1978 | A |
4129903 | Huggler | Dec 1978 | A |
4187559 | Grell et al. | Feb 1980 | A |
4224699 | Weber | Sep 1980 | A |
4274164 | Rehder et al. | Jun 1981 | A |
4312079 | Dorre et al. | Jan 1982 | A |
4314381 | Koeneman | Feb 1982 | A |
4332036 | Sutter et al. | Jun 1982 | A |
4454612 | McDaniel et al. | Jun 1984 | A |
4488320 | Wilson | Dec 1984 | A |
4530114 | Tepic | Jul 1985 | A |
4532661 | Halpern | Aug 1985 | A |
4546501 | Gustilo et al. | Oct 1985 | A |
4549319 | Meyer | Oct 1985 | A |
4608052 | Van Kampen et al. | Aug 1986 | A |
4608055 | Morrey et al. | Aug 1986 | A |
4619659 | Witzel | Oct 1986 | A |
4623349 | Lord | Nov 1986 | A |
4645506 | Link | Feb 1987 | A |
4661112 | Muller | Apr 1987 | A |
4664668 | Beck et al. | May 1987 | A |
4670015 | Freeman | Jun 1987 | A |
4676799 | Legrand | Jun 1987 | A |
4681590 | Tansey | Jul 1987 | A |
4686971 | Harris et al. | Aug 1987 | A |
RE32488 | Gustilo | Sep 1987 | E |
4693724 | Rhenter et al. | Sep 1987 | A |
4718912 | Crowninshield | Jan 1988 | A |
4718916 | Morscher | Jan 1988 | A |
4728334 | Spotorno | Mar 1988 | A |
4728335 | Jurgutis | Mar 1988 | A |
4731088 | Collier | Mar 1988 | A |
4750905 | Koeneman et al. | Jun 1988 | A |
4752296 | Buechel et al. | Jun 1988 | A |
4770660 | Averill | Sep 1988 | A |
4770661 | Oh | Sep 1988 | A |
4775381 | Tari et al. | Oct 1988 | A |
4778469 | Lin et al. | Oct 1988 | A |
4790852 | Noiles | Dec 1988 | A |
4792337 | Muller | Dec 1988 | A |
4795472 | Crowninshield | Jan 1989 | A |
4795473 | Grimes | Jan 1989 | A |
4822368 | Collier | Apr 1989 | A |
4840632 | Kampner | Jun 1989 | A |
4846839 | Noiles | Jul 1989 | A |
4846840 | Leclercq et al. | Jul 1989 | A |
4846841 | Oh | Jul 1989 | A |
4851004 | Homsy | Jul 1989 | A |
4851007 | Gray | Jul 1989 | A |
4851008 | Johnson | Jul 1989 | A |
4871369 | Muller | Oct 1989 | A |
4878917 | Kranz et al. | Nov 1989 | A |
4881536 | Noble et al. | Nov 1989 | A |
4888023 | Averill et al. | Dec 1989 | A |
4888024 | Powlan | Dec 1989 | A |
4892551 | Haber | Jan 1990 | A |
4904266 | Barber | Feb 1990 | A |
4904268 | Alvarado | Feb 1990 | A |
4908034 | Weightman et al. | Mar 1990 | A |
4908036 | Link et al. | Mar 1990 | A |
4911722 | Crespy | Mar 1990 | A |
4936863 | Hofmann | Jun 1990 | A |
4938771 | Vecsei et al. | Jul 1990 | A |
4938773 | Strand | Jul 1990 | A |
4944761 | Stuhmer et al. | Jul 1990 | A |
4944762 | Link et al. | Jul 1990 | A |
4976740 | Kleiner | Dec 1990 | A |
4986834 | Smith et al. | Jan 1991 | A |
4995883 | Demane et al. | Feb 1991 | A |
4998937 | Grimes | Mar 1991 | A |
5002578 | Luman | Mar 1991 | A |
5002579 | Copf et al. | Mar 1991 | A |
5002580 | Noble et al. | Mar 1991 | A |
5002581 | Paxson et al. | Mar 1991 | A |
5004476 | Cook | Apr 1991 | A |
5007935 | Vincent et al. | Apr 1991 | A |
5030234 | Pappas et al. | Jul 1991 | A |
5035712 | Hoffman | Jul 1991 | A |
5035717 | Brooks | Jul 1991 | A |
5047060 | Henssge et al. | Sep 1991 | A |
5047062 | Pappas et al. | Sep 1991 | A |
5057101 | Dorr et al. | Oct 1991 | A |
5080685 | Bolesky et al. | Jan 1992 | A |
5087260 | Fixel | Feb 1992 | A |
5108451 | Forte | Apr 1992 | A |
5108452 | DeMane et al. | Apr 1992 | A |
5116377 | Skripitz et al. | May 1992 | A |
5116380 | Hewka et al. | May 1992 | A |
5133764 | Pappas et al. | Jul 1992 | A |
5133766 | Halpern | Jul 1992 | A |
5152795 | Sioshansi et al. | Oct 1992 | A |
5156624 | Barnes | Oct 1992 | A |
5163963 | Hewka et al. | Nov 1992 | A |
5163964 | Lazzeri et al. | Nov 1992 | A |
5181928 | Bolesky et al. | Jan 1993 | A |
5197988 | Spotorno et al. | Mar 1993 | A |
5197989 | Hinckfuss et al. | Mar 1993 | A |
5197990 | Lawes et al. | Mar 1993 | A |
5201771 | Belykh et al. | Apr 1993 | A |
5201882 | Paxson | Apr 1993 | A |
5222985 | Homsy | Jun 1993 | A |
5246461 | Tepic | Sep 1993 | A |
5258033 | Lawes et al. | Nov 1993 | A |
5286260 | Bolesky et al. | Feb 1994 | A |
5314489 | Hoffman et al. | May 1994 | A |
5336265 | Serbousek et al. | Aug 1994 | A |
5370706 | Bolesky et al. | Dec 1994 | A |
5376124 | Gustke et al. | Dec 1994 | A |
5376125 | Winkler | Dec 1994 | A |
5376126 | Lin | Dec 1994 | A |
5387244 | Breard | Feb 1995 | A |
5389107 | Nassar et al. | Feb 1995 | A |
5458653 | Davidson | Oct 1995 | A |
5458654 | Tepic | Oct 1995 | A |
5468243 | Halpern | Nov 1995 | A |
5480452 | Hoffmann | Jan 1996 | A |
5480453 | Burke | Jan 1996 | A |
5507814 | Gilbert et al. | Apr 1996 | A |
5507830 | DeMane et al. | Apr 1996 | A |
5514182 | Shea | May 1996 | A |
5514184 | Doi et al. | May 1996 | A |
5549704 | Sutter | Aug 1996 | A |
5571195 | Johnson | Nov 1996 | A |
5571203 | Masini | Nov 1996 | A |
5591233 | Kelman et al. | Jan 1997 | A |
5653764 | Murphy | Aug 1997 | A |
5653765 | McTighe et al. | Aug 1997 | A |
5702448 | Buechel et al. | Dec 1997 | A |
5702483 | Kwong | Dec 1997 | A |
5702487 | Averil et al. | Dec 1997 | A |
5725590 | Maumy et al. | Mar 1998 | A |
5725592 | Whit et al. | Mar 1998 | A |
5725593 | Caracciolo | Mar 1998 | A |
5725594 | McTighe et al. | Mar 1998 | A |
5725595 | Gustilo | Mar 1998 | A |
5746771 | Clement, Jr. | May 1998 | A |
5755807 | Anstaett et al. | May 1998 | A |
5800553 | Albrektson et al. | Sep 1998 | A |
5800560 | Draenert | Sep 1998 | A |
5814050 | Benson | Sep 1998 | A |
5858020 | Johnson et al. | Jan 1999 | A |
5861042 | Buechel | Jan 1999 | A |
5876459 | Powell | Mar 1999 | A |
5888208 | Ro | Mar 1999 | A |
5906644 | Powell | May 1999 | A |
5954771 | Richelsoph | Sep 1999 | A |
5980575 | Albrektsson et al. | Nov 1999 | A |
6010535 | Shah | Jan 2000 | A |
6120544 | Grundei et al. | Sep 2000 | A |
6179877 | Burke | Jan 2001 | B1 |
6193761 | Treacy | Feb 2001 | B1 |
6197065 | Martin et al. | Mar 2001 | B1 |
6231611 | Mosseri | May 2001 | B1 |
6273915 | Grimes | Aug 2001 | B1 |
6284002 | Sotereanos | Sep 2001 | B1 |
6290726 | Pope et al. | Sep 2001 | B1 |
6371991 | Manasas et al. | Apr 2002 | B1 |
6379390 | Advani | Apr 2002 | B1 |
6383226 | Carter | May 2002 | B1 |
6383227 | Baroud | May 2002 | B1 |
6395004 | Dye | May 2002 | B1 |
6402753 | Cole | Jun 2002 | B1 |
6402787 | Pope | Jun 2002 | B1 |
6413280 | Deiler | Jul 2002 | B1 |
6428578 | White | Aug 2002 | B2 |
6432141 | Stocks | Aug 2002 | B1 |
6482237 | Mosseri | Nov 2002 | B2 |
6488714 | Keller | Dec 2002 | B2 |
6488716 | Huang | Dec 2002 | B1 |
6503281 | Mallory | Jan 2003 | B1 |
6514288 | Meulink | Feb 2003 | B2 |
6524343 | Storer | Feb 2003 | B2 |
20020072805 | Sullivan | Jun 2002 | A1 |
20020107520 | Hoffman | Aug 2002 | A1 |
20020111692 | Ralph | Aug 2002 | A1 |
20020133234 | Sotereanos | Sep 2002 | A1 |
20020143402 | Steinberg | Oct 2002 | A1 |
20020156536 | Harris | Oct 2002 | A1 |
20030014123 | Copf et al. | Jan 2003 | A1 |
20030033020 | Hunter et al. | Feb 2003 | A1 |
20030045941 | Lewallen | Mar 2003 | A1 |
20030050704 | Keynan | Mar 2003 | A1 |
20030060891 | Shah | Mar 2003 | A1 |
20030065397 | Hansen | Apr 2003 | A1 |
20030074079 | McTighe | Apr 2003 | A1 |
20030074080 | Murray | Apr 2003 | A1 |
20030074083 | LeGros | Apr 2003 | A1 |
20030088316 | Ganjianpour | May 2003 | A1 |
20030109933 | Weissman | Jun 2003 | A1 |
20030120347 | Steinberg | Jun 2003 | A1 |
20030130740 | Stocks | Jul 2003 | A1 |
20030171819 | Sotereanos | Sep 2003 | A1 |
Number | Date | Country |
---|---|---|
145617 | Jun 1985 | EP |
128036 | May 1987 | EP |
220803 | May 1987 | EP |
065481 | Aug 1987 | EP |
266081 | May 1988 | EP |
145617 | Jun 1988 | EP |
310566 | Apr 1989 | EP |
159510 | May 1990 | EP |
539036 | Apr 1993 | EP |
539036 | Nov 1996 | EP |
761183 | May 2002 | EP |
728449 | Jul 2002 | EP |
1234556 | Aug 2002 | EP |
841041 | Sep 2002 | EP |
1240879 | Sep 2002 | EP |
966240 | Oct 2002 | EP |
852931 | Feb 2003 | EP |
WO8700033 | Jan 1987 | WO |
WO9600539 | Jan 1996 | WO |
WO9806359 | Feb 1998 | WO |
WO0048535 | Aug 2000 | WO |
WO03007852 | Jan 2003 | WO |
WO03094703 | Nov 2003 | WO |
WO03094803 | Nov 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20110004319 A1 | Jan 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12429882 | Apr 2009 | US |
Child | 12882399 | US | |
Parent | 10763314 | Jan 2004 | US |
Child | 12429882 | US |